AllerGen researchers appointed to Hydra Biosciences Advisory Board
AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a …
AllerGen researchers appointed to Hydra Biosciences Advisory Board Read more »